Skip to main content
. Author manuscript; available in PMC: 2009 May 19.
Published in final edited form as: JAMA. 2008 Aug 27;300(8):924–932. doi: 10.1001/jama.300.8.924

Table 3.

Effect of Placebo and Allopurinol on Non–Blood Pressure End Points

Mean (95% Confidence Interval)
Parameter Pretreatmenta Placebo Allopurinol P Value
Heart rate, beats/min 72 (67–78) 74 (69–80) 75 (69–80) .87
Cardiac output, L/min 6.4 (5.6–7.1) 6.2 (5.4–7.0) 6.6 (5.9–7.2) .56
Systemic vascular resistance index, (dyne s/cm5)/m2 2478 (2223–2731) 2473 (2232–2615) 2136 (2056–2228) .03b
Total body water, L 27.8 (26.0–29.7) 28.0 (26.1–30.1) 28.1 (26.0–29.9) .86
Plasma renin activity, ng/mL/h 1.9 (1.7–2.2) 2.1 (1.8–2.4) 1.4 (0.8–2.1) .02b
a

Pretreatment values were measured prior to first treatment phase.

b

Exploratory end points.